The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high-grade serous carcinoma on the ARIEL2 trial.
 
Anna Piskorz
No Relationships to Disclose
 
Kevin K. Lin
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
James Anthony Morris
Stock and Other Ownership Interests - Inivata
Patents, Royalties, Other Intellectual Property - Inivata
Other Relationship - Inivata
 
Elaina Mann
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Amit M. Oza
Honoraria - WebRx
Consulting or Advisory Role - Amgen; Clovis Oncology; Immunovaccine; Verastem
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; DOD-CDRMP; Esperance Pharmaceuticals; Genentech/Roche; NCCN
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bayer; Clovis Oncology; Gradalis; Merck; Merrimack; Millennium
 
David M. O'Malley
Consulting or Advisory Role - Eisai; Janssen Oncology
Research Funding - Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Research & Development (Inst); Regeneron (Inst); VentiRx (Inst)
 
Michael Friedlander
Honoraria - Clovis Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche
Research Funding - AstraZeneca (Inst)
 
Janiel M. Cragun
Research Funding - Clovis Oncology (Inst)
 
Ling Ma
Consulting or Advisory Role - bioTheranostics
 
Heidi Giordano
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Mitch Raponi
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Iain A. McNeish
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Research Funding - Clovis Oncology (Inst)
 
Elizabeth M. Swisher
Travel, Accommodations, Expenses - Clovis Oncology
 
James D. Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Speakers' Bureau - AstraZeneca
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Clovis Oncology